Rabbit Anti-KRT16 Recombinant Antibody (CBCNC-628) (CBMAB-C3801-CN)

Name: Rabbit Anti-KRT16 Recombinant Antibody (CBCNC-628)
SKU: CBMAB-C3801-CN
Rating: 5 (1 reviews)

See all KRT16 antibodies

Compare Online Inquiry

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal

Rabbit

Clone

CBCNC-628

Application

WB, IHC-P, IF, FC

Immunogen

Recombinant protein

Specificity

Human

Antibody Isotype

IgG

Clonality

Monoclonal

Application Notes

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format

Liquid

Buffer

1 x TBS, pH 7.4, 1% BSA, 40% Glycerol

More Infomation

Target

Full Name

Keratin 16

Introduction

The protein encoded by this gene is a member of the keratin gene family. The keratins are intermediate filament proteins responsible for the structural integrity of epithelial cells and are subdivided into cytokeratins and hair keratins. Most of the type I cytokeratins consist of acidic proteins which are arranged in pairs of heterotypic keratin chains and are clustered in a region of chromosome 17q12-q21. This keratin has been coexpressed with keratin 14 in a number of epithelial tissues, including esophagus, tongue, and hair follicles. Mutations in this gene are associated with type 1 pachyonychia congenita, non-epidermolytic palmoplantar keratoderma and unilateral palmoplantar verrucous nevus. [provided by RefSeq, Jul 2008]

Entrez Gene ID

3868

UniProt ID

P08779

Alternative Names

Keratin 16; Focal Non-Epidermolytic Palmoplantar Keratoderma; Keratin 16, Type I; KRT16A; K16; Keratin, Type I Cytoskeletal 16; Cytokeratin 16; Cytokeratin-16;

Function

Epidermis-specific type I keratin that plays a key role in skin. Acts as a regulator of innate immunity in response to skin barrier breach: required for some inflammatory checkpoint for the skin barrier maintenance.

Biological Process

AgingManual Assertion Based On ExperimentIDA:UniProtKB
Cytoskeleton organization1 PublicationNAS:UniProtKB
Establishment of skin barrierISS:UniProtKB
Hair cycleManual Assertion Based On ExperimentIDA:UniProtKB
Inflammatory responseISS:UniProtKB
Innate immune responseISS:UniProtKB
Intermediate filament cytoskeleton organizationIEA:Ensembl
KeratinizationISS:UniProtKB
Keratinocyte differentiationISS:UniProtKB
Keratinocyte migrationISS:UniProtKB
Morphogenesis of an epitheliumISS:UniProtKB
Negative regulation of cell migrationManual Assertion Based On ExperimentIDA:UniProtKB

Cellular Location

Cytoskeleton
Cytosol
Extracellular exosome
Intermediate filament
Nucleus

Involvement in disease

Pachyonychia congenita 1 (PC1):
An autosomal dominant ectodermal dysplasia characterized by hypertrophic nail dystrophy resulting in onchyogryposis (thickening and increase in curvature of the nail), palmoplantar keratoderma, follicular hyperkeratosis, and oral leukokeratosis. Hyperhidrosis of the hands and feet is usually present.
Keratoderma, palmoplantar, non-epidermolytic, focal 1 (FNEPPK1):
A dermatological disorder characterized by non-epidermolytic palmoplantar keratoderma limited to the pressure points on the balls of the feet, with later mild involvement on the palms. Oral, genital and follicular keratotic lesions are often present.
KRT16 and KRT17 are coexpressed only in pathological situations such as metaplasias and carcinomas of the uterine cervix and in psoriasis vulgaris.

Lu, Z., Peng, H., Li, R., Xu, X., & Peng, J. (2022). BarH-like homeobox 2 represses the transcription of keratin 16 and affects Ras signaling pathway to suppress nasopharyngeal carcinoma progression. Bioengineered, 13(2), 3122-3136.

Elazezy, M., Schwentesius, S., Stegat, L., Wikman, H., Werner, S., Mansour, W. Y., ... & Joosse, S. A. (2021). Emerging insights into keratin 16 expression during metastatic progression of breast cancer. Cancers, 13(15), 3869.

Zhang, X., Yin, M., & Zhang, L. J. (2019). Keratin 6, 16 and 17—critical barrier alarmin molecules in skin wounds and psoriasis. Cells, 8(8), 807.

Huang, W. C., Jang, T. H., Tung, S. L., Yen, T. C., Chan, S. H., & Wang, L. H. (2019). A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway. Journal of Experimental & Clinical Cancer Research, 38, 1-17.

Zieman, A. G. (2018). A role for keratin 16 in the regulation of epithelial differentiation and homeostasis in glabrous epidermis (Doctoral dissertation, Johns Hopkins University).

Zieman, A., & Coulombe, P. A. (2018). The keratin 16 null phenotype is modestly impacted by genetic strain background in mice. Experimental dermatology, 27(6), 672-674.

Zhang, J., Li, X., Chen, H., Lu, Y., Li, L., Han, L., & Lu, C. (2018). Gallic acid inhibits the expression of keratin 16 and keratin 17 through Nrf2 in psoriasis-like skin disease. International Immunopharmacology, 65, 84-95.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Rabbit Anti-KRT16 Recombinant Antibody (CBCNC-628)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Related Products

Mouse Anti-KRT16 Recombinant Antibody (7A4) (CAT#: CBMAB-K1651-LY)

Mouse Anti-KRT16 Recombinant Antibody (6F6) (CAT#: CBMAB-EN852-LY)

Mouse Anti-KRT16 Recombinant Antibody (0.N.361) (CAT#: CBMAB-K1639-LY)

Mouse Anti-KRT16 Recombinant Antibody (6A11) (CAT#: CBMAB-K1648-LY)

Mouse Anti-KRT16 Recombinant Antibody (A794) (CAT#: CBMAB-AP4152LY)

Mouse Anti-KRT16 Recombinant Antibody (CBYY-C2975) (CAT#: CBMAB-C4418-YY)

Mouse Anti-KRT16 Recombinant Antibody (2F10) (CAT#: CBMAB-K1645-LY)

Mouse Anti-KRT16 Recombinant Antibody (2E6) (CAT#: CBMAB-K1644-LY)

Mouse Anti-KRT16 Recombinant Antibody (LL025) (CAT#: CBMAB-K1652-LY)

Mouse Anti-KRT16 Recombinant Antibody (6A401) (CAT#: CBMAB-K1649-LY)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry